skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Inhibitor Recognition Specificity of MERS-CoV Papain-like Protease May Differ from That of SARS-CoV

Journal Article · · ACS Chem. Biol.
DOI:https://doi.org/10.1021/cb500917m· OSTI ID:1188829

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
National Institutes of Health (NIH)
OSTI ID:
1188829
Journal Information:
ACS Chem. Biol., Vol. 10, Issue (6) ; 06, 2015
Country of Publication:
United States
Language:
ENGLISH
Citation Metrics:
Cited by: 79 works
Citation information provided by
Web of Science

References (38)

Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia journal November 2012
Structure-Based Design, Synthesis, and Biological Evaluation of a Series of Novel and Reversible Inhibitors for the Severe Acute Respiratory Syndrome−Coronavirus Papain-Like Protease journal August 2009
Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease journal March 2014
Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic? journal December 2012
Human Coronavirus EMC Does Not Require the SARS-Coronavirus Receptor and Maintains Broad Replicative Capability in Mammalian Cell Lines journal December 2012
A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication journal October 2008
Structural Basis for the Ubiquitin-Linkage Specificity and deISGylating Activity of SARS-CoV Papain-Like Protease journal May 2014
Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans journal November 2012
Crystal structure of a deubiquitinating enzyme (human UCH-L3) at 1.8 Å resolution journal July 1997
Synergistic Inhibitor Binding to the Papain-Like Protease of Human SARS Coronavirus: Mechanistic and Inhibitor Design Implications journal June 2013
Bats Are Natural Reservoirs of SARS-Like Coronaviruses journal October 2005
Features and development of Coot journal March 2010
Structure and mechanisms of the proteasome-associated deubiquitinating enzyme USP14 journal October 2005
REFMAC 5 dictionary: organization of prior chemical knowledge and guidelines for its use journal November 2004
Severe acute respiratory syndrome coronavirus papain-like protease: Structure of a viral deubiquitinating enzyme journal March 2006
Mechanisms and enzymes involved in SARS coronavirus genome expression journal September 2003
Hospital Outbreak of Middle East Respiratory Syndrome Coronavirus journal August 2013
Molecular biology of severe acute respiratory syndrome coronavirus journal August 2004
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus journal November 2003
Genetic Characterization of Betacoronavirus Lineage C Viruses in Bats Reveals Marked Sequence Divergence in the Spike Protein of Pipistrellus Bat Coronavirus HKU5 in Japanese Pipistrelle: Implications for the Origin of the Novel Middle East Respiratory Syndrome Coronavirus journal May 2013
Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group journal May 2013
Crystal Structure of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Papain-like Protease Bound to Ubiquitin Facilitates Targeted Disruption of Deubiquitinating Activity to Demonstrate Its Role in Innate Immune Suppression journal December 2014
Drug Design Targeting the Main Protease, the Achilles Heel of Coronaviruses journal December 2006
Severe Acute Respiratory Syndrome Coronavirus Papain-like Novel Protease Inhibitors: Design, Synthesis, Protein−Ligand X-ray Structure and Biological Evaluation journal July 2010
Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats journal September 2005
Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual and high-throughput screenings journal January 2014
X-ray Structural and Biological Evaluation of a Series of Potent and Highly Selective Inhibitors of Human Coronavirus Papain-like Proteases journal March 2014
The Papain-Like Protease of Severe Acute Respiratory Syndrome Coronavirus Has Deubiquitinating Activity journal November 2005
Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission journal June 2013
XDS journal January 2010
Crystal structure of the papain-like protease of MERS coronavirus reveals unusual, potentially druggable active-site features journal September 2014
MERS-CoV papain-like protease has deISGylating and deubiquitinating activities journal February 2014
Structural basis for conformational plasticity of the Parkinson's disease-associated ubiquitin hydrolase UCH-L1 journal March 2006
Phaser crystallographic software journal July 2007
First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013 journal June 2013
Emerging Human Coronaviruses — Disease Potential and Preparedness journal November 2012
Pleiotropic Effects of Ubp6 Loss on Drug Sensitivities and Yeast Prion Are Due to Depletion of the Free Ubiquitin Pool journal December 2003
A novel coronavirus capable of lethal human infections: an emerging picture journal February 2013

Cited By (16)

Development of Small-Molecule MERS-CoV Inhibitors journal December 2018
Molecular Dynamics and Inhibition of MERS CoV Papain-like Protease by Small Molecule Imidazole and Aminopurine Derivatives journal April 2019
Coronaviruses — drug discovery and therapeutic options journal February 2016
Potent and selective inhibition of pathogenic viruses by engineered ubiquitin variants journal May 2017
Recent progress in the discovery of inhibitors targeting coronavirus proteases journal February 2016
Structural and mutational analysis of the interaction between the Middle-East respiratory syndrome coronavirus (MERS-CoV) papain-like protease and human ubiquitin journal May 2016
In search of drugs to alleviate suppression of the host's innate immune responses against SARS-CoV-2 using a molecular modeling approach journal April 2021
Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes journal February 2018
Structure-guided design of potent and permeable inhibitors of MERS coronavirus 3CL protease that utilize a piperidine moiety as a novel design element journal April 2018
Molecular Characteristics, Functions, and Related Pathogenicity of MERS-CoV Proteins journal October 2019
Structure and Function of Viral Deubiquitinating Enzymes journal November 2017
Middle East respiratory syndrome coronavirus: transmission, virology and therapeutic targeting to aid in outbreak control journal August 2015
Drug repurposing against MERS CoV and SARS-COV-2 PLpro in silico journal March 2020
Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via high-throughput screening and molecular modeling text January 2022
In silico Drug Repurposing for COVID-19: Targeting SARS-CoV-2 Proteins through Docking and Quantum Mechanical Scoring preprint May 2020
UL36 Encoded by Marek’s Disease Virus Exhibits Linkage-Specific Deubiquitinase Activity journal March 2020